相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The β-Secretase BACE1 in Alzheimer's Disease
Harald Hampel et al.
BIOLOGICAL PSYCHIATRY (2021)
Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations
Tsz Hang Wong et al.
NEUROBIOLOGY OF AGING (2020)
Phytol loaded PLGA nanoparticles regulate the expression of Alzheimer's related genes and neuronal apoptosis against amyloid-β induced toxicity in Neuro-2a cells and transgenic Caenorhabditis elegans
Sethuraman Sathya et al.
FOOD AND CHEMICAL TOXICOLOGY (2020)
Preparation and in vitro evaluation of multi-target-directed selenium-chondroitin sulfate nanoparticles in protecting against the Alzheimer's disease
Fei Gao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease
Carina Wattmo et al.
BMC NEUROLOGY (2020)
Recent Advances on Antitumor Agents-loaded Polymeric and Lipid-based Nanocarriers for the Treatment of Brain Cancer
Amanda Cano et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
Ultrasmall superparamagnetic iron oxide nanoparticles-bound NIR dyes: Novel theranostic agents for Alzheimer's disease
Jing Cai et al.
DYES AND PIGMENTS (2020)
Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers
John J. E. Mulvihill et al.
NANOMEDICINE (2020)
Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and nanotherapy
Hossein Derakhshankhah et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
Serum neurofilament light levels in normal aging and their association with morphologic brain changes
Michael Khalil et al.
NATURE COMMUNICATIONS (2020)
Astrocyte and Oligodendrocyte Cross-Talk in the Central Nervous System
Erik Nutma et al.
CELLS (2020)
Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer's Disease
Dong Eun Kim et al.
BRAIN SCIENCES (2020)
Carbon dots sensitized lanthanide infinite coordination polymer nanoparticles: Towards ratiometric fluorescent sensing of cerebrospinal Aβ monomer as a biomarker for Alzheimer's disease
Chang Liu et al.
ANALYTICA CHIMICA ACTA (2020)
Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease
R. G. R. Pinheiro et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer's disease
Sun Ah Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
Elena Sanchez-Lopez et al.
NANOMATERIALS (2020)
A dual-ligand fusion peptide improves the brain-neuron targeting of nanocarriers in Alzheimer's disease mice
Qian Guo et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Novel biosensor for acetylcholine based on acetylcholinesterase/poly (neutral red) - Deep eutectic solvent/Fe2O3 nanoparticle modified electrode
Wanderson da Silva et al.
JOURNAL OF ELECTROANALYTICAL CHEMISTRY (2020)
TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K/Akt pathway after intracerebral hemorrhage in mice
Shengpan Chen et al.
JOURNAL OF NEUROINFLAMMATION (2020)
A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer's disease
Montserrat Alegret et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
The potential role of pomegranate and its nano -formulations on cerebral neurons in aluminum chloride induced Alzheimer rat model
Mohammed S. Almuhayawi et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2020)
Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases
Amanda Cano et al.
NANOMEDICINE (2020)
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence
Jason T. Duskey et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
Evaluation of neurological effects of cerium dioxide nanoparticles doped with different amounts of zirconium following inhalation exposure in mouse models of Alzheimer's and vascular disease
Tina Wahle et al.
NEUROCHEMISTRY INTERNATIONAL (2020)
A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study
Merce Boada et al.
ALZHEIMERS & DEMENTIA (2020)
Early diagnosis of Alzheimer's disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts
P. M. Rossini et al.
CLINICAL NEUROPHYSIOLOGY (2020)
Deciphering the anti-apoptotic potential of α-bisabolol loaded solid lipid nanoparticles against Aβ induced neurotoxicity in Neuro-2a cells
Sethuraman Sathya et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2020)
Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
Michael Ewers et al.
EMBO Molecular Medicine (2020)
Cationic biopolymer functionalized nanoparticles encapsulating lutein to attenuate oxidative stress in effective treatment of Alzheimer's disease: A non-invasive approach
Namdev Dhas et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
Sebastian Palmqvist et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
A comprehensive review on green synthesis of nature-inspired metal nanoparticles: Mechanism, application and toxicity
Anu Rana et al.
JOURNAL OF CLEANER PRODUCTION (2020)
Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease
Nicolas R. Barthelemy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease
Niklas Mattsson-Carlgren et al.
BRAIN (2020)
Transferrin' across the blood-brain barrier
Joseph Willson
NATURE REVIEWS DRUG DISCOVERY (2020)
Mitochondrial dysfunction and Alzheimer's disease: prospects for therapeutic intervention
Ji Woong Lim et al.
BMB REPORTS (2020)
Sustained release of bioactive hydrogen by Pd hydride nanoparticles overcomes Alzheimer's disease
Lei Zhang et al.
BIOMATERIALS (2019)
SNAP-25 in Serum Is Carried by Exosomes of Neuronal Origin and Is a Potential Biomarker of Alzheimer's Disease
Cristina Agliardi et al.
MOLECULAR NEUROBIOLOGY (2019)
A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward
Michael E. Belloy et al.
NEURON (2019)
Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model
Li Zhong et al.
NATURE COMMUNICATIONS (2019)
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease
Philip S. J. Weston et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases
Anarmaa Mendsaikhan et al.
CELLS (2019)
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
Alberto Lleo et al.
ALZHEIMERS & DEMENTIA (2019)
Search for biomarkers of Alzheimer's disease: Recent insights, current challenges and future prospects
Katerina Hrubesova et al.
CLINICAL BIOCHEMISTRY (2019)
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
Amanda Cano et al.
JOURNAL OF CONTROLLED RELEASE (2019)
The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications
Amaia M. Arranz et al.
LANCET NEUROLOGY (2019)
Vitamin D-binding protein-loaded PLGA nanoparticles suppress Alzheimer's disease-related pathology in 5XFAD mice
Seong Gak Jeon et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
Niklas Mattsson et al.
JAMA NEUROLOGY (2019)
A metabolic perspective of late onset Alzheimer's disease
Miren Ettcheto et al.
PHARMACOLOGICAL RESEARCH (2019)
Protein-Capped Metal Nanoparticles Inhibit Tau Aggregation in Alzheimer's Disease
Shweta Kishor Sonawane et al.
ACS OMEGA (2019)
Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer's disease
Yanan Liu et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2019)
Magnetic nanoparticles in nanomedicine: a review of recent advances
Kai Wu et al.
NANOTECHNOLOGY (2019)
Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities
Anne-Laure Hemonnot et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer's disease induced by β-amyloid 1-42 peptide in aged female mice
Renata Giacomeli et al.
BRAIN RESEARCH (2019)
Metal nanoparticles synthesis: An overview on methods of preparation, advantages and disadvantages, and applications
Prasad Govindrao Jamkhande et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2019)
Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology
Asa Sandelius et al.
ALZHEIMERS & DEMENTIA (2019)
Methodological Issues in the Clinical Validation of Biomarkers for Alzheimer's Disease: The Paradigmatic Example of CSF
Marco Canevelli et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease
Christopher D. Whelan et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Blood-based biomarkers for Alzheimer's disease-An update
Henrik Zetterberg
JOURNAL OF NEUROSCIENCE METHODS (2019)
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Emma Nichols et al.
LANCET NEUROLOGY (2019)
Biomarkers for tau pathology
Michael Scholl et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2019)
Cationic carrier peptide enhances cerebrovascular targeting of nanoparticles in Alzheimer's disease brain
Kristen M. Ahlschwede et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction
Daniel A. Nation et al.
NATURE MEDICINE (2019)
Improvement of memory deficits in the rat model of Alzheimer's disease by erythropoietin-loaded solid lipid nanoparticles
Tahereh Dara et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2019)
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
Isabelle Bos et al.
ALZHEIMERS & DEMENTIA (2019)
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study
Virginia Perez-Grijalba et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Anticholinergic Drugs in Geriatric Psychopharmacology
Jorge Lopez-Alvarez et al.
FRONTIERS IN NEUROSCIENCE (2019)
Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis
Kunal Dhiman et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer's disease
Marta Mila-Aloma et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress
Merce Boada et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
Michelle M. Mielke et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment
Yong Shen et al.
BIOLOGICAL PSYCHIATRY (2018)
Microglia-Mediated Neuroprotection, TREM2, and Alzheimer's Disease: Evidence From Optical Imaging
Carlo Condello et al.
BIOLOGICAL PSYCHIATRY (2018)
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
Harald Hampel et al.
BRAIN (2018)
Tau Proteins and Tauopathies in Alzheimer's Disease
Fong Ping Chong et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease
Barbara Mroczko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease
Che-Chuan Yang et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
α-Bisabolol loaded solid lipid nanoparticles attenuates Aβ aggregation and protects Neuro-2a cells from Aβ induced neurotoxicity
Sethuraman Sathya et al.
JOURNAL OF MOLECULAR LIQUIDS (2018)
Biomarkers for Alzheimer Disease: Classical and Novel Candidates' Review
Nadia El Kadmiri et al.
NEUROSCIENCE (2018)
The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease
Bianca A. Trombetta et al.
PLOS ONE (2018)
Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis
Che-Sheng Chu et al.
SCIENTIFIC REPORTS (2018)
TREM2-Dependent Effects on Microglia in Alzheimer's Disease
Yingyue Zhou et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Phytol: A review of biomedical activities
Muhammad Torequl Islam et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease
Andrew J. Aschenbrenner et al.
NEUROLOGY (2018)
APOE ε4 is associated with higher levels of CSF SNAP-25 in prodromal Alzheimer's disease
Shanshan Wang et al.
NEUROSCIENCE LETTERS (2018)
Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease
Hua Zhang et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease
Hua Zhang et al.
TRANSLATIONAL NEURODEGENERATION (2018)
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline
Marc Suárez‐Calvet et al.
EMBO Molecular Medicine (2018)
Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release
Aldemar Gordillo-Galeano et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Applications of Noble Metal-Based Nanoparticles in Medicine
Bartosz Klebowski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer's disease
Simone Lista et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Cerebrospinal Fluid A beta(42/40) Corresponds Better than A beta(42) to Amyloid PET in Alzheimer's Disease
Piotr Lewczuk et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer's disease
Simone Lista et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases
Filippo Baldacci et al.
EXPERT REVIEW OF PROTEOMICS (2017)
A sensitive and selective electrochemical biosensor for the determination of beta-amyloid oligomer by inhibiting the peptide-triggered in situ assembly of silver nanoparticles
Yun Xing et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Polymeric nanoparticles: Promising platform for drug delivery
Khalid M. El-Say et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons
Ravi Rajmohan et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Biomedical applications of green synthesized Nobel metal nanoparticles
Zia Ul Haq Khan et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2017)
The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases
Yu-Ping Jia et al.
MOLECULES (2017)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease (vol 537, pg 50, 2016)
Jeff Sevigny et al.
NATURE (2017)
Neuroprotective effects of erythropoietin on Alzheimer's dementia model in rats
Betul Cevik et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2017)
Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
Rose Ann Huynh et al.
FRONTIERS IN NEUROLOGY (2017)
Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation
Francesca Regen et al.
CURRENT ALZHEIMER RESEARCH (2017)
Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers
Matthew W. Wong et al.
ALZHEIMERS & DEMENTIA (2017)
Gold nanoparticle-capped mesoporous silica-based H2O2-responsive controlled release system for Alzheimer's disease treatment
Licong Yang et al.
ACTA BIOMATERIALIA (2016)
Neuroinflammation in Alzheimer's disease: Current evidence and future directions
Valeria Calsolaro et al.
ALZHEIMERS & DEMENTIA (2016)
Protective role of epigallocatechin-3-gallate in health and disease: A perspective
Animesh Chowdhury et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease
Carlo Wilke et al.
CURRENT ALZHEIMER RESEARCH (2016)
A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging
Eric A. Tanifum et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Methods for the Specific Detection and Quantitation of Amyloid-beta Oligomers in Cerebrospinal Fluid
Judith Schuster et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Alzheimer's disease: An overview of amyloid beta dependent pathogenesis and its therapeutic implications along with in silico approaches emphasizing the role of natural products
Manika Awasthi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer Management By Albumin Replacement) study
M. Boada et al.
NEUROLOGIA (2016)
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease
Annika Ohrfelt et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Mechanisms of Aβ Clearance and Degradation by Glial Cells
Miriam Ries et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease
Rawan Tarawneh et al.
JAMA NEUROLOGY (2016)
Mitochondrial Dysfunction in Alzheimer's Disease and the Rationale for Bioenergetics Based Therapies
Isaac G. Onyango et al.
AGING AND DISEASE (2016)
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients
Shashank Shekhar et al.
PLOS ONE (2016)
Role of oxidative stress in Alzheimer's disease
Wen-Juan Huang et al.
BIOMEDICAL REPORTS (2016)
Targeting neuroinflammation in Alzheimer's disease
Maria Rosanna Bronzuoli et al.
JOURNAL OF INFLAMMATION RESEARCH (2016)
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
Kaj Blennow et al.
ALZHEIMERS & DEMENTIA (2015)
Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson's Disease
Juha Punnonen et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
Controlled Drug Delivery: Historical perspective for the next generation
Yeon Hee Yun et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Importance of selenium and selenoprotein for brain function: From antioxidant protection to neuronal signalling
Nikolay D. Solovyev
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay
Wendy E. Heywood et al.
MOLECULAR NEURODEGENERATION (2015)
Surface charge-conversion polymeric nanoparticles for photodynamic treatment of urinary tract bacterial infections
Shijie Liu et al.
NANOTECHNOLOGY (2015)
Vascular dysfunction in the pathogenesis of Alzheimer's disease - A review of endothelium-mediated mechanisms and ensuing vicious circles
Luigi Yuri Di Marco et al.
NEUROBIOLOGY OF DISEASE (2015)
Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy
Famida G. Hoosain et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Vitamin D Binding Protein as a Serum Biomarker of Alzheimer's Disease
Ram J. Bishnoi et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease
Kirsten L. Viola et al.
NATURE NANOTECHNOLOGY (2015)
Advances and new technologies applied in controlled drug delivery system
Fatma Bassyouni et al.
RESEARCH ON CHEMICAL INTERMEDIATES (2015)
Soluble BACE-1 Activity and sA beta PP beta Concentrations in Alzheimer's Disease and Age-Matched Healthy Control Cerebrospinal Fluid from the Alzheimer's Disease Neuroimaging Initiative-1 Baseline Cohort
Mary J. Savage et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
A practical algorithm for managing Alzheimer's disease: what, when, and why?
Jeffrey L. Cummings et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer's Disease
Magdalena Groblewska et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Cerebrospinal fluid BACE1 activity and markers of amyloid precursor protein metabolism and axonal degeneration in Alzheimer's disease
Robert Perneczky et al.
ALZHEIMERS & DEMENTIA (2014)
Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease
Cassia R. Overk et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Emerging Research and Clinical Development Trends of Liposome and Lipid Nanoparticle Drug Delivery Systems
John C. Kraft et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
The blood-brain barrier: Structure, function and therapeutic approaches to cross it
Marta Tajes et al.
MOLECULAR MEMBRANE BIOLOGY (2014)
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
Tobias Skillback et al.
NEUROLOGY (2014)
Therapeutics of Alzheimer's disease: Past, present and future
R. Anand et al.
NEUROPHARMACOLOGY (2014)
The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's disease
Takahisa Kanekiyo et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Controlled drug delivery systems: the next 30 years
Yeonhee Yun et al.
FRONTIERS OF CHEMICAL SCIENCE AND ENGINEERING (2014)
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Subash C. Gupta et al.
AAPS JOURNAL (2013)
Glyconanoparticle Aided Detection of β-Amyloid by Magnetic Resonance Imaging and Attenuation of β-Amyloid Induced Cytotoxicity
Hovig Kouyoumdjian et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Thorlakur Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine - searching for the connections
Wojciech Danysz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Chondroitin sulfate: A key molecule in the brain matrix
J. C. F. Kwok et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Nanoparticles as drug delivery systems
Agnieszka Z. Wilczewska et al.
PHARMACOLOGICAL REPORTS (2012)
Loss of orally administered drugs in GI tract
Yogeshkumar Nanasaheb Gavhane et al.
SAUDI PHARMACEUTICAL JOURNAL (2012)
Increased CSF-BACE1 Activity Associated with Decreased Hippocampus Volume in Alzheimer's Disease
Michael Ewers et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Lydia Alvarez-Erviti et al.
NATURE BIOTECHNOLOGY (2011)
Biodegradable polymeric nanoparticles based drug delivery systems
Avnesh Kumari et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease
Adam Smith et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
BACE1 Activity in Cerebrospinal Fluid and Its Relation to Markers of AD Pathology
Sandra D. Mulder et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
A Review of the Application and Pharmacological Properties of alpha-Bisabolol and alpha-Bisabolol-Rich Oils
Guy P. P. Kamatou et al.
JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY (2010)
Revising the definition of Alzheimer's disease: a new lexicon
Bruno Dubois et al.
LANCET NEUROLOGY (2010)
The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia Two Roads Converged
Suzanne Craft
ARCHIVES OF NEUROLOGY (2009)
Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease
Annette Maczurek et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases
Jing Zhang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles
Christian Wischke et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Etazolate, a neuroprotective drug linking GABAA receptor pharmacology to amyloid precursor protein processing
M. Marcade et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Glutamate enhances proliferation and neurogenesis in human neural progenitor cell cultures derived from the fetal cortex
Masatoshi Suzuki et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles
Catarina Pinto Reis et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2006)
The use of biopharmaceutic classification of drugs in drug discovery and development:: current status and future extension
H Lennernäs et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2005)
Neurofilament protein in cerebrospinal fluid:: A marker of white matter changes
M Sjögren et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
Oxidative damage is the earliest event in Alzheimer disease
A Nunomura et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
分享论文
